Thermo Fishr Sci Stock Price, News & Analysis

Thermo Fisher Scientific (NYSE:TMO) released its annual Corporate Social Responsibility report, emphasizing progress in environmental, social, and governance (ESG) objectives. Key highlights include a 12% reduction in Scope 1 and 2 emissions since 2018, commitment to net-zero emissions by 2050, and an increase in spending with underrepresented businesses from $1.3 billion to $2.0 billion. The company also engaged over 100,000 students in STEM programs and logged 105,000 volunteer hours globally.

Thermo Fisher Scientific Inc. (NYSE: TMO) announced a quarterly cash dividend of $0.30 per common share on May 18, 2022. The dividend will be payable on July 15, 2022, to shareholders of record as of June 15, 2022. The company, a leading name in serving science, reported an annual revenue of approximately $40 billion. Thermo Fisher aims to enhance health, safety, and environment through its extensive range of innovative technologies and services.

Thermo Fisher Scientific Inc. (NYSE: TMO) announced that its CEO, Marc N. Casper, will present at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022, at 12:20 p.m. EDT. The presentation will be accessible via a webcast on the company's Investor Relations page. Thermo Fisher Scientific reported annual revenues of approximately $40 billion, focusing on making the world healthier, cleaner, and safer through innovative technologies and pharmaceutical services. For more details, visit www.thermofisher.com.

Thermo Fisher Scientific reported first-quarter 2022 revenue of $11.82 billion, achieving 19% growth year-over-year. The company's GAAP diluted EPS was $5.61, down from $5.88 in Q1 2021, while adjusted EPS rose to $7.25. The results highlighted 16% core organic growth and $1.68 billion from COVID-19 testing. The launch of innovative products and a 15-year collaboration with Moderna for mRNA vaccine manufacturing were key highlights. The company also repurchased $2.0 billion in stock and increased its dividend by 15%.

Portal Innovations has partnered with Life Technologies Corporation, part of Thermo Fisher Scientific (NYSE: TMO), to enhance life sciences research capabilities. This collaboration aims to provide advanced lab equipment and infrastructure to startups at Portal’s 50,000 sq ft facility in Chicago. Patrick Flavin, President of Portal, emphasized that this partnership will allow member companies to accelerate their research and development efforts. Portal focuses on seed investments, management expertise, and access to top-tier lab space to support high-potential life sciences companies.

Thermo Fisher Scientific (NYSE:TMO) will host its 2022 Investor Day on May 18 at 9:00 a.m. (ET), held at Mandarin Oriental New York. The event will feature presentations from senior management and include a Q&A session. Investors can access a live webcast on the company's website, with a replay available later. Thermo Fisher is a global leader in serving science with approximately $40 billion in annual revenue, dedicating efforts to health, safety, and research through innovative technologies and services.

Thermo Fisher Scientific Inc. (NYSE: TMO) will release its financial results for Q1 2022 before the market opens on April 28, 2022, with a conference call scheduled for 8:30 a.m. EST on the same day. The call will outline the company's financial performance and future expectations. Investors can access the call at (844) 200-6205 in the U.S. or (929) 526-1599 internationally, using access code 310385. The press release and additional details will be available on their website.

Thermo Fisher Scientific Inc. (NYSE: TMO) will have its chairman and CEO, Marc N. Casper, present virtually at Cowen’s 42nd Annual Conference on March 7, 2022, at 10:30 a.m. (EST). The conference will be available via webcast on their website. Thermo Fisher, a global leader in serving science, reported annual revenues of approximately $40 billion, supporting advancements in life sciences, diagnostics, and pharmaceutical development.

Thermo Fisher Scientific (NYSE: TMO) has announced a quarterly cash dividend of $0.30 per common share, marking a 15% increase from the previous $0.26. The dividend is payable on April 14, 2022, to shareholders of record as of March 16, 2022. With annual revenues of approximately $40 billion, Thermo Fisher continues to advance its mission of enabling healthier and safer outcomes worldwide.